FDA clears Mauna Kea Technologies NIR miniprobes for use in urology, surgery

June 1, 2016
The FDA has cleared a line of confocal miniprobes indicated for use in urological and minimally invasive surgical applications.

Mauna Kea Technologies (Paris, France) has received FDA clearance for the company's confocal miniprobes indicated for use in urological and minimally invasive surgical applications with the company's near-infrared (NIR) Cellvizio confocal laser endomicroscopy (CLE) platform.

Related: FDA approves laser endomicroscopy system for intraoperative use

Image-guided surgery with intraoperative macroscopic fluorescence systems provides surgeons with enhanced anatomical guidance. The addition of microscopic fluorescence tissue pathological assessment may provide immediate, actionable information that may be used to improve diagnostic potential and further guide surgical treatments. The Cellvizio platform with NIR miniprobes will be compatible and complementary to existing macroscopic NIR endoscopic platforms proposed by a majority of surgical endoscopy manufacturers.

For more information, please visit www.maunakeatech.com.

Sponsored Recommendations

March 31, 2025
Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
March 31, 2025
Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
March 31, 2025
Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
March 31, 2025
Filter accessories including cubes, sliders, and rings, designed to enhance the performance and versatility of optical systems. These components ensure precise alignment and stability...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!